Full Breakdown
Candida auris Cases Surge Across U.S. Healthcare Facilities
8/5/2026, 4:42:04 PM
Core Event
The drug-resistant fungus *Candida auris* continues to spread in U.S. hospitals and nursing homes. CDC data show a rise from 2,882 reported cases in 2022 to 4,428 in 2023 and 6,197 in 2024. As of July 18, Texas leads with 706 cases, followed by Michigan and Illinois. Tennessee reported 283 confirmed cases through July 25, up from 10 a year earlier. Most infections occur in acute-care settings, affect patients over age 45 (about 88 % of cases), and are more common among men.
Background & Context
*Candida auris* was first identified in the United States in 2013 and classified by the CDC as an “urgent threat.” Certain strains resist all standard antifungal classes, earning the label “superbug.” The organism can persist on surfaces for weeks and spread via catheters, breathing tubes, or IV lines, making infection control critical.
Data & Statistics
- 2022-2024 CDC reports: 2,882 -> 4,428 -> 6,197 cases nationwide.
- State totals (2024): Texas 706, Michigan 503, Illinois 366, Tennessee 283, Ohio 279, Georgia 193.
- Demographics: 88 % of cases involve patients >= 45 years; a majority are male; most occur in acute-care facilities.
- Mortality: Estimates range from 30 % to 60 % of infected patients, many of whom had additional serious illnesses.
- Resistance: Multiple strains are resistant to azoles and, in some instances, to amphotericin B.
Official Statements & Responses
The CDC’s Mycotic Diseases branch emphasizes early detection and strict infection-control practices. CDC epidemiologist Dr. Meghan Lyman highlighted the need for expanded laboratory capacity, faster diagnostics, and adherence to prevention protocols. Guidance advises gowns and gloves, private isolation rooms, and rigorous disinfection of high-touch surfaces. Dr. Tom Chiller reiterated that “early detection and infection control in hospitals and nursing homes is the most important way to stop its spread.”
Conflicting Reports & Gaps
Outlets report varying cumulative case counts. Healthline cites 6,197 cases nationwide in 2024, while People notes 3,130 confirmed cases as of July 18 that year. NTD reports 3,437 cumulative cases across 27 states in 2026. Mortality estimates also differ, reflecting gaps in real-time surveillance and standardized reporting.
Verbatim Quotes
- “The rapid emergence around the world and the speed of spread in the U.S. is alarming,” — Susan Huang
- “Candida auris is a troublesome fungal infection,” — Dr. William Schaffner, MD, Vanderbilt University
- “Fungal infections are often overlooked because they are not as common as bacterial infections,” — Nathan Wiederhold
What’s Next
The CDC will continue nationwide surveillance, expand laboratory testing, and promote rapid diagnostic tools. Healthcare facilities are urged to maintain heightened screening, isolation, and environmental cleaning protocols to limit further transmission.
